We're closely monitoring the spread of COVID-19 and our priority is continuing to deliver care to the women who need us. Click here to read more.

Choose a country

Latin America
North America
West Asia and Middle East

Contact details

Find country

Marie Stopes International comment on introduction of Sayana Press self-injectable contraceptive to UK

Thursday 24 September 2015 Marie Stopes International Press release UK

Share this publication

Drug company Pfizer has announced it will launch its Sayana Press self-injectable contraceptive for women in the UK to use at home.

Responding to the news, Genevieve Edwards, Director of Policy at Marie Stopes UK, said: "We've found that being able to self-inject is very popular with women living in remote communities around the world who find it difficult to get to a clinic four times a year.  It may have a similar appeal for women in the UK who’d rather inject at home and have annual check ups, and if it frees up precious time for nurses and doctors, that can only be a good thing. 

“There are now more ways for women to manage their fertility than ever before, and yet the contraceptive Pill remains by far the most usually prescribed method, despite now not being the most effective. This development serves as a useful reminder to women to explore all the options available to them – it’s highly likely there’s a method available that’s better suited to your life stage and life style.”

For journalist enquiries, please contact the Marie Stopes International press office on 07769 166 516 or email

Share this

Back to news